ECM
TRAW icon

ETrade Capital Management’s Traws Pharma TRAW Stock Holding History

ETrade Capital Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$6K Buy
+59
New +$14.6K ﹤0.01% 882

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $5.7B AUM 21.25% 1-Year Est. Return

ETrade Capital Management's TRAW Position: Q3 2020 in Review

ETrade Capital Management opened a new position in Traws Pharma (TRAW) in Q3 2020: 59 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #882 among its holdings.

30 funds tracked by Wall St. Rank hold TRAW as of Q3 2020.

  • ETrade Capital Management held 59 shares of Traws Pharma worth $6K as of Q3 2020.
  • Traws Pharma was a new ETrade Capital Management position in Q3 2020.
  • Traws Pharma made up ﹤0.01% of ETrade Capital Management's portfolio in Q3 2020, its #882 holding.
  • 30 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.